[ESPR] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
01-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 44.03%
YoY- 37.79%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 137,735 32,250 33,969 25,786 24,329 18,818 18,980 274.37%
PBT 61,022 -56,344 -41,250 -49,935 -61,719 -55,487 -55,117 -
Tax -41 -27,424 -26 -51 27,501 12,974 13,494 -
NP 61,022 -56,344 -41,250 -49,935 -89,220 -68,461 -68,611 -
Tax Rate 0.07% - - - - - - -
Total Cost 76,713 88,594 75,219 75,721 113,549 87,279 87,591 -8.45%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 44.30 -174.71 -121.43 -193.65 -366.72 -363.81 -361.49 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS 0.36 -0.50 -0.37 -0.46 -1.14 -0.93 -1.01 -
EPS Diluted 0.34 -0.50 -0.37 -0.46 -1.14 -0.93 -1.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.